GHP Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329K | Hold |
4,771
| – | – | 0.01% | 335 |
|
2025
Q1 | $331K | Buy |
4,771
+33
| +0.7% | +$2.29K | 0.02% | 331 |
|
2024
Q4 | $408K | Buy |
4,738
+178
| +4% | +$15.3K | 0.02% | 310 |
|
2024
Q3 | $543K | Sell |
4,560
-134
| -3% | -$16K | 0.02% | 300 |
|
2024
Q2 | $670K | Buy |
4,694
+134
| +3% | +$19.1K | 0.03% | 283 |
|
2024
Q1 | $586K | Hold |
4,560
| – | – | 0.03% | 297 |
|
2023
Q4 | $472K | Hold |
4,560
| – | – | 0.03% | 310 |
|
2023
Q3 | $466K | Hold |
4,560
| – | – | 0.03% | 306 |
|
2023
Q2 | $414K | Hold |
4,560
| – | – | 0.02% | 319 |
|
2023
Q1 | $363K | Sell |
4,560
-110
| -2% | -$8.75K | 0.02% | 320 |
|
2022
Q4 | $316K | Hold |
4,670
| – | – | 0.02% | 330 |
|
2022
Q3 | $233K | Buy |
4,670
+110
| +2% | +$5.49K | 0.02% | 337 |
|
2022
Q2 | $254K | Sell |
4,560
-194
| -4% | -$10.8K | 0.02% | 330 |
|
2022
Q1 | $264K | Buy |
4,754
+194
| +4% | +$10.8K | 0.02% | 330 |
|
2021
Q4 | $255K | Hold |
4,560
| – | – | 0.02% | 296 |
|
2021
Q3 | $219K | Buy |
+4,560
| New | +$219K | 0.02% | 291 |
|